Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.7732
-0.0211 (-2.66%)
At close: Sep 15, 2025, 4:00 PM EDT
0.7835
+0.0103 (1.33%)
After-hours: Sep 15, 2025, 7:58 PM EDT

Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $76.28 million. The enterprise value is $21.95 million.

Market Cap76.28M
Enterprise Value 21.95M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, before market open.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

Immunic has 98.65 million shares outstanding. The number of shares has increased by 50.88% in one year.

Current Share Class 98.65M
Shares Outstanding 98.65M
Shares Change (YoY) +50.88%
Shares Change (QoQ) +30.42%
Owned by Insiders (%) 1.76%
Owned by Institutions (%) 29.97%
Float 65.25M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.25
P/TBV Ratio 2.25
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.03.

Current Ratio 2.19
Quick Ratio 2.05
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -208.93% and return on invested capital (ROIC) is -132.35%.

Return on Equity (ROE) -208.93%
Return on Assets (ROA) -88.95%
Return on Invested Capital (ROIC) -132.35%
Return on Capital Employed (ROCE) -308.55%
Revenue Per Employee n/a
Profits Per Employee -$1.12M
Employee Count91
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -49.13% in the last 52 weeks. The beta is 1.44, so Immunic's price volatility has been higher than the market average.

Beta (5Y) 1.44
52-Week Price Change -49.13%
50-Day Moving Average 0.89
200-Day Moving Average 0.99
Relative Strength Index (RSI) 40.01
Average Volume (20 Days) 1,383,880

Short Selling Information

The latest short interest is 9.83 million, so 9.97% of the outstanding shares have been sold short.

Short Interest 9.83M
Short Previous Month 9.65M
Short % of Shares Out 9.97%
Short % of Float 15.07%
Short Ratio (days to cover) 9.10

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -105.27M
Pretax Income -95.31M
Net Income -101.84M
EBITDA -105.10M
EBIT -105.27M
Earnings Per Share (EPS) -$0.94
Full Income Statement

Balance Sheet

The company has $55.31 million in cash and $979,000 in debt, giving a net cash position of $54.33 million or $0.55 per share.

Cash & Cash Equivalents 55.31M
Total Debt 979,000
Net Cash 54.33M
Net Cash Per Share $0.55
Equity (Book Value) 33.91M
Book Value Per Share 0.34
Working Capital 32.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$90.14 million and capital expenditures -$136,000, giving a free cash flow of -$90.28 million.

Operating Cash Flow -90.14M
Capital Expenditures -136,000
Free Cash Flow -90.28M
FCF Per Share -$0.92
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -50.88%
Shareholder Yield -50.88%
Earnings Yield -133.51%
FCF Yield -118.36%

Analyst Forecast

The average price target for Immunic is $7.50, which is 870.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.50
Price Target Difference 870.00%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1